Drug Delivery Technologies: Commercial Prospects 2012-2022
http://www.reportlinker.com/p0335692/Drug-Delivery-Technologies-Commercial-Prospects-2012-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Report Details
How to find industry trends and revenue prospects there
What does the future hold for drug delivery technologies? Visiongain's report shows you potential revenues and other trends, with data, forecasts and discussions.
This decade, many commercial opportunities for improved drug delivery exist. You discover sales predictions to 2022 at world market, submarket, application and national level.
In particular, our report forecasts six submarkets to 2022, showing you potential revenues:
• Oral delivery
• Inhaled delivery
• Transdermal delivery
• Ocular delivery
• Nasal delivery
• Implants for drug delivery.
The study discusses 3M, Catalent, Alkermes, Generex Biotechnology, pSivida and many other technology providers, letting you assess outlooks for the industry and market.
How will biological drugs using the technologies perform from 2012? You find overall revenues from nine pharmaceutical areas predicted to 2022:
• Monoclonal antibodies
• Insulins
• Erythropoietins
• Interferons
• G-CSF agents
• Recombinant coagulation factors
• Other therapeutic proteins
• Biosimilars and related agents
• Vaccines.
Our investigation gives you business research and analysis with many forecasts.
Where is drug delivery heading? Technologies and applications giving improved clinical efficacy, patient convenience and treatment compliance will achieve success.
Drug delivery R&D is promising. Suppliers and users of the technology will benefit. Our calculations show you the potential for expanded revenues to 2022.
Which areas of pharma will benefit most? Drug delivery technologies offer many opportunities for pharma line extensions and product lifecycle management, benefiting a wide range of drugs. Biologicals and vaccines will profit especially. You see how.
In our analysis, the drug delivery technology industry will achieve high revenue growth from 2012 to 2022. In particular, greater use of injectable drugs and vaccines worldwide will stimulate demand for innovative delivery systems.
We find wide scope for novel and improved drug delivery from 2012 onwards, seeing many sales opportunities for products and services there. Our report explains.
Visiongain's study provides data, analysis and opinion aiming to benefit your research, calculations and presentations. You find answers in our work.
Revenue forecasts, market shares, developmental trends and discussions
In our report you find revenue forecasting, growth rates and market shares. Also, you have qualitative analyses (SWOT and STEP) and discussion of technologies, existing and in development. You receive 90 tables and charts and four research interviews.
Advantages of Drug Delivery Technologies: Commercial Prospects 2012-2022 for your work
In particular, this study gives you the following knowledge:
• Find potential revenues to 2022 for the world market and submarkets
• See market forecasting to 2022 for US, Japan, EU5, China and India
• Receive forecasts to 2022 for drug classes using the systems
• Assess leading companies, discovering activities and outlooks
• Review technological developments, assessing trends and prospects
• Investigate competition and opportunities influencing revenues
• Find out what will stimulate and restrain the industry and market
• View opinions from our survey, receiving four interviews.
There, you find an original mix of quantitative and qualitative analyses with independent predictions. Receive data that only our report contains, harnessing our pharma knowledge.
Through our analytical methods we keep you informed about commercial trends and prospects. By getting our report now, you could find that information before your competitors.
Gain business research and analysis now for drug delivery technology
Our study is for everybody needing industry and market analyses for drug delivery technologies. You find data, trends and answers there. Avoid missing out - please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Table of Contents
1. Executive Summary
1.1 Drug Delivery Technology: Market Review
1.2 Aims, Scope and Format of Report
1.2.1 Chapter Outlines
1.3 Research and Analysis Methods
2. Introduction
2.1 Introduction to Drug Delivery Technologies (DDT)
2.2 Types of Technologies for Drug Delivery
2.2.1 Sustained/Controlled Release Systems
2.2.2 Injection
2.2.3 Needle-Free Injection
2.2.4 Pulmonary, Buccal and Nasal Delivery
2.2.5 Pills and Capsules
2.3 Biopharmaceuticals
2.3.1 Overview of the Biologicals Market
2.3.2 The Biological Drug Industry is Strong
2.4 Biotech Drugs with Associated Drug Delivery Technologies
2.4.1 Pegylated Interferons
2.4.2 Crowded Insulin Market Has Forced Investment in Drug Delivery
2.5 Exubera - Case Study for Alternative Biological Delivery Methods
2.5.1 The First Inhaled Insulin
2.5.2 Description and Development History
2.5.3 Generex and MannKind Developing Next-Generation Oral Insulins
2.5.4 Challenges Facing Afrezza and Oral-lyn
2.6 The Main Challenges for Biological Drug Delivery
3. The World Drug Delivery Technology Market to 2022
3.1 The World Drug Delivery Technology Market: Overview
3.2 Growing Market for Drug Delivery Technology and Services
3.2.1 Revenue Forecast for Overall Drug Delivery Technology Market, 2011-2016
3.2.2 Revenue Forecast for Overall Drug Delivery Technology Market, 2017-2022
3.3 Breakdown of the Global Drug Delivery Technology Market
3.3.1 Revenue Forecast for Oral Drug Delivery Technology, 2011-2016
3.3.2 Revenue Forecast for Oral Drug Delivery Technology, 2017-2022
3.3.3 Revenue Forecast for Inhalation Drug Delivery Technology, 2011-2016
3.3.4 Revenue Forecast for Inhalation Drug Delivery Technology, 2017-2022
3.3.5 Revenue Forecast for Transdermal Drug Delivery Technology, 2011-2016
3.3.6 Revenue Forecast for Transdermal Drug Delivery Technology, 2017-2022
3.3.7 Revenue Forecast for Injectable/Implants Drug Delivery Technology, 2011-2016
3.3.8 Revenue Forecast for Injectable/Implants Drug Delivery Technology, 2017-2022
3.3.9 Revenue Forecast for Ocular Drug Delivery Technology, 2011-2016
3.3.10 Revenue Forecast for Ocular Drug Delivery Technology, 2017-2022
3.3.11 Revenue Forecast for Nasal Drug Delivery Technology, 2011-2016
3.3.12 Revenue Forecast for Nasal Drug Delivery Technology, 2017-2022
3.4 Leading National Markets for Drug Delivery Technology
3.4.1 The US Drug Delivery Technology Market, 2012-2022
3.4.2 The Japanese Drug Delivery Technology Market, 2012-2022
3.4.3 The Leading European Drug Delivery Technology Markets, 2012-2022
3.4.4 Emerging-Economy Drug Delivery Technology Markets
3.4.5 The Chinese Drug Delivery Technology Market, 2012-2022
3.4.6 The Indian Drug Delivery Technology Market, 2012-2022
4. Drug Classes That Can Benefit from Advances in Drug Delivery
4.1 Therapeutic Areas Offering Growth Opportunities
4.1.1 Sales of Biologics Will Stimulate Developments in Drug Delivery
4.1.2 Leading Segments of the Biological Drugs Market in 2011
4.1.3 Monoclonal Antibodies Lead the Biologics Market
4.1.3.1 Prospects for Monoclonal Antibodies and Implications for Drug Delivery
4.1.4 The Human Insulins Class will Exhibit Strong Growth
4.1.5 Erythropoietin Products - What are the Future Prospects?
4.1.5.1 Erythropoietin Products Forecast, 2012-2022
4.1.6 The Interferons Class will Show an Increase in Revenues from 2011-2016
4.1.6.1 Long-Term Forecast for the Interferons Class
4.1.7 Granular-Colony Stimulating Factors (G-CSF) Forecast, 2012-2022
4.1.8 Recombinant Coagulation Factors Will Show Steady Growth
4.1.9 Other Therapeutic Proteins
4.1.10 The Biosimilars Market, 2011
4.1.10.1 Forecast for the Biosimilars Market, 2012-2022
4.1.11 Forecast for the Vaccines Market, 2012-2022
4.2 The Drug Delivery Technology Market: Conclusions
Be the first to review this article
